Finance / GTCB (GTC Biotherapeutics Inc)

gtc-BIOTHERAPEUTICS RECEIVES NASDAQ NOTICE FRAMINGHAM, MA – November 11, 2008 -- GTC Biotherapeutics, Inc. ("GTC" or “the Company”, Nasdaq: GTCB) received notice from the Listing Qualifications Staff (“Staff”) of The NASDAQ Stock Market indicating that GTC no longer satisfies the minimum $2.5 million stockholders’ equity requirement for continued listing on The NASDAQ Capital Market, as set forth...

gtc-BIOTHERAPEUTICS RECEIVES NASDAQ NOTICE FRAMINGHAM, MA – November 11, 2008 -- GTC Biotherapeutics, Inc. ("GTC" or “the Company”, Nasdaq: GTCB) received notice from the Listing Qualifications Staff (“Staff”) of The NASDAQ Stock Market indicating that GTC no longer satisfies the minimum $2.5 million stockholders’ equity requirement for continued listing on The NASDAQ Capital Market, as...

  Recs: 0 Re: AMD stock price OK, I've made a list as follows , sorted by biggest DOWN movement since 20 days . Criteria .... Current price between 0.01$ adn 1.01$ Total Cash - Total Debt greater than 0 Absolute price movement over last 20 days worse than 20% down ! Maybe you can see a few stock picks amongst them ?   SYMBOL  COMPANY...

Here’s the full 3Q08 PR for archival purposes. The main points have been covered in prior posts today: 1) the $15M convertible financing; 2) the transfer of EU ATryn rights from Leo to LFB; and 3) the end of the Merrimack MM-093 program (as we surmised). Cash on hand at 9/28/08 was $8.8M; this of course excludes the proceeds from the proposed $15M financing, which requires ...

Press Release Source: GTC Biotherapeutics, Inc. GTC Signs Agreement for $15 Million Convertible Debt Financing From LFB Monday November 3, 7:00 am ET Financing Subject to Shareholder Approval FRAMINGHAM, Mass.--(BUSINESS WIRE)--GTC Biotherapeutics, Inc.’s ("GTC", Nasdaq: GTCB) signed an agreement with LFB Biotechnologies, its collaboration partner for a number of recombinant ...

GTC Biotherapeutics to Announce Third Quarter 2008 Earnings on Monday, November 3, 2008 Date : 10/29/2008 @ 3:52PM Source : Business Wire Stock : GTC Biotherapeutics, Inc. (GTCB) Quote : 0.3215 -0.0185 (-5.44%) @ 3:41PM GTC Biotherapeutics to Announce Third Quarter 2008 Earnings on Monday, November 3, 2008 GTC Biotherapeutics, Inc. (Nasdaq:GTCB) (“GTC”) will ...